Zobrazeno 1 - 10
of 114
pro vyhledávání: '"Reiichi Murakami"'
Autor:
Tomohiko Matsuura, Moe Toyoshima, Mitsuru Saitoh, Hayato Nishida, Shingo Hatakeyama, Shinya Maita, Reiichi Murakami, Jun Sugimura, Takaya Abe, Hirofumi Tomita, Hisao Saitoh, Norihiko Tsuchiya, Chikara Ohyama, Tomonori Habuchi, Wataru Obara
Publikováno v:
Renal Replacement Therapy, Vol 10, Iss 1, Pp 1-8 (2024)
Abstract Background This study aimed to compare the outcomes of living donor kidney transplantation with blood- and non-blood-related donors across multiple facilities. Previous reports comparing these outcomes have been single-center studies. As the
Externí odkaz:
https://doaj.org/article/0fd608e5ff754654b3beffefedad1e70
Autor:
Tomoko Hamaya, Shingo Hatakeyama, Tohru Yoneyama, Yuki Tobisawa, Hirotake Kodama, Takeshi Fujita, Reiichi Murakami, Kazuyuki Mori, Teppei Okamoto, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Hisao Saitoh, Shunji Narumi, Hirofumi Tomita, Chikara Ohyama
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-8 (2023)
Abstract We aimed to evaluate the humoral response after the second and third doses of SARS-CoV-2 mRNA vaccine in ABO blood type incompatible kidney transplant (KT) recipients treated with rituximab. This retrospective study conducted between June 20
Externí odkaz:
https://doaj.org/article/3f7ccf5e416d46c6a7cff32e5a334931
Autor:
Tomoko Hamaya, Shingo Hatakeyama, Tohru Yoneyama, Yuki Tobisawa, Hirotake Kodama, Takeshi Fujita, Reiichi Murakami, Naoki Fujita, Teppei Okamoto, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Hisao Saitoh, Shunji Narumi, Hirofumi Tomita, Chikara Ohyama
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-7 (2022)
Abstract We aimed to evaluate the seroprevalence and investigated factors associated with seropositivity after the second SARS-CoV-2 mRNA vaccination in kidney transplant (KT) recipients. This retrospective study conducted between June and November 2
Externí odkaz:
https://doaj.org/article/2eff230bfea644a8b44b8c662ee172c2
Autor:
Takeshi Fujita, Hideyuki Nakagawa, Takashi Yokota, Jun Umetani, Daiki Nagawa, Masamichi Nakata, Ikuyo Narita-Kinjo, Reiichi Murakami, Michiko Shimada, Norio Nakamura, Hirofumi Tomita
Publikováno v:
Case Reports in Nephrology and Dialysis, Vol 11, Iss 2, Pp 227-232 (2021)
Nintedanib is a unique tyrosine kinase inhibitor used to suppress fibrosis in patients with idiopathic pulmonary fibrosis (IPF). Nintedanib has been shown to suppress multiple processes of fibrosis, thereby reducing the rate of lung function decline
Externí odkaz:
https://doaj.org/article/1b1b74cdc7c340ea831c2cb159b62d7e
Autor:
HIROSHI OSAWA, NORIO NAKAMURA, CHIKAKO TSUTAYA, HISAO SAITOH, MICHIKO SHIMADA, REIICHI MURAKAMI, TAKESHI FUJITA, IKUYO NARITA-KINJO, DAIKI NAGAWA, MASAMICHI NAKATA, TAKASHI YOKOTA, CHIKARA OHYAMA, HIROFUMI TOMITA
Publikováno v:
In Vivo; May/Jun2024, Vol. 38 Issue 3, p1351-1358, 8p
Autor:
Norio Nakamura, Masamichi Nakata, Daiki Nagawa, Ikuyo Narita, Takeshi Fujita, Reiichi Murakami, Michiko Shimada, Hirofumi Tomita
Publikováno v:
Case Reports in Nephrology, Vol 2020 (2020)
Pneumoperitoneum, the presence of free air within the peritoneal cavity, is often caused by the perforation of gas-containing viscus and commonly requires surgical treatment. However, in patients with peritoneal dialysis, free air is commonly seen on
Externí odkaz:
https://doaj.org/article/0f65d4ce72cf428884a8043814cde15b
Autor:
Kazufumi Kato, Reiichi Murakami, Hiroshi Shiroto, Daiki Nagawa, Ikuyo Narita-Kinjo, Takeshi Fujita, Michiko Shimada, Hirofumi Tomita
Publikováno v:
CEN Case Reports. 12:221-225
A 72-year-old Japanese woman was treated by 3000 mg/day of valacyclovir for the herpes zoster in her left back. She had been treated as hypertension with no renal insufficiency. In two days, she visited an emergency room of a regional stroke care cen
Autor:
Michiko Shimada, Norio Nakamura, Tetsu Endo, Hideaki Yamabe, Masayuki Nakamura, Reiichi Murakami, Ikuyo Narita, Hirofumi Tomita
Publikováno v:
BMC Nephrology, Vol 18, Iss 1, Pp 1-4 (2017)
Abstract Background Direct-acting antivirals (DAAs) dramatically improve the treatment of hepatitis C virus (HCV) infections. However, the effects of DAAs on extra-hepatic manifestations such as HCV-associated glomerulonephritis, especially in cases
Externí odkaz:
https://doaj.org/article/3877902fd21548619d05a50338d1a70e
Autor:
NORIO NAKAMURA, HIROSHI OSAWA, DAIKI NAGAWA, MASAMICHI NAKATA, IKUYO NARITA-KINJO, TAKESHI FUJITA, REIICHI MURAKAMI, MICHIKO SHIMADA, HIROFUMI TOMITA, CHIKAKO TSUTAYA, HISAO SAITO, TADASHI SUZUKI
Publikováno v:
In Vivo
Background/Aim: Cardiovascular disease (CVD) is a frequent complication in hemodialysis (HD) patients, especially when the underlying disease is diabetes mellitus (DM). In this study, we investigated cardiovascular events and lipid and fatty acid pro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5edfe358f276041ecce325741b94d8dd
https://europepmc.org/articles/PMC10188032/
https://europepmc.org/articles/PMC10188032/
Autor:
DAIKI NAGAWA, MICHIKO SHIMADA, MASAMICHI NAKATA, IKUYO NARITA-KINJO, TAKESHI FUJITA, REIICHI MURAKAMI, NORIO NAKAMURA, HIROFUMI TOMITA
Publikováno v:
In Vivo; Nov/Dec2023, Vol. 37 Issue 6, p2437-2446, 10p